Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1994 1
2001 2
2002 1
2003 2
2004 1
2006 3
2008 2
2009 2
2010 3
2012 1
2014 1
2015 3
2016 2
2017 2
2018 3
2020 6
2021 9
2022 8
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
The ANTES program in COPD: First year.
Agustí A, Alcázar B, Ancochea J, Casanova C, Celli B, Cosio B, Echave-Sustaeta JM, Fernandez Villar A, Garcia Rivero JL, González C, Izquierdo JL, Lopez-Campos JL, Marín Trigo JM, Martín Sánchez J, Miravitlles M, Molina J, Peces-Barba G, Roman M, Soler Cataluña JJ, Villar-Alvarez F. Agustí A, et al. Among authors: izquierdo jl. Arch Bronconeumol. 2022 Apr;58(4):291-294. doi: 10.1016/j.arbres.2021.10.009. Epub 2021 Nov 19. Arch Bronconeumol. 2022. PMID: 35312529 Free article. English, Spanish. No abstract available.
Time for a change: anticipating the diagnosis and treatment of COPD.
Agusti A, Alcazar B, Cosio B, Echave JM, Faner R, Izquierdo JL, Marin JM, Soler-Cataluña JJ, Celli B; Scientific Committee of the ANTES programme. Agusti A, et al. Among authors: izquierdo jl. Eur Respir J. 2020 Jul 30;56(1):2002104. doi: 10.1183/13993003.02104-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32732302 Free article. No abstract available.
Roflumilast for COPD.
Izquierdo JL, Aparicio J. Izquierdo JL, et al. Drugs Today (Barc). 2010 Nov;46(11):823-31. doi: 10.1358/dot.2010.46.11.1521831. Drugs Today (Barc). 2010. PMID: 21225021 Review.
Exacerbations in COPD: a personalised approach to care.
José Soler-Cataluña J, Miravitlles M, Fernández-Villar A, Izquierdo JL, García-Rivero JL, Cosio BG, López-Campos JL, Agustí A; ANTES panellists. José Soler-Cataluña J, et al. Among authors: izquierdo jl. Lancet Respir Med. 2023 Mar;11(3):224-226. doi: 10.1016/S2213-2600(22)00533-1. Epub 2023 Feb 10. Lancet Respir Med. 2023. PMID: 36780913 No abstract available.
Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD.
Rossi A, Aisanov Z, Avdeev S, Di Maria G, Donner CF, Izquierdo JL, Roche N, Similowski T, Watz H, Worth H, Miravitlles M. Rossi A, et al. Among authors: izquierdo jl. Respir Med. 2015 Jul;109(7):785-802. doi: 10.1016/j.rmed.2015.03.010. Epub 2015 Apr 3. Respir Med. 2015. PMID: 25892293 Free article. Review.
The impact of COVID-19 on patients with asthma.
Izquierdo JL, Almonacid C, González Y, Del Rio-Bermudez C, Ancochea J, Cárdenas R, Lumbreras S, Soriano JB. Izquierdo JL, et al. Eur Respir J. 2021 Mar 4;57(3):2003142. doi: 10.1183/13993003.03142-2020. Print 2021 Mar. Eur Respir J. 2021. PMID: 33154029 Free PMC article.
Consensus document on the overlap phenotype COPD-asthma in COPD.
Soler-Cataluña JJ, Cosío B, Izquierdo JL, López-Campos JL, Marín JM, Agüero R, Baloira A, Carrizo S, Esteban C, Galdiz JB, González MC, Miravitlles M, Monsó E, Montemayor T, Morera J, Ortega F, Peces-Barba G, Puente L, Rodríguez JM, Sala E, Sauleda J, Soriano JB, Viejo JL. Soler-Cataluña JJ, et al. Among authors: izquierdo jl. Arch Bronconeumol. 2012 Sep;48(9):331-7. doi: 10.1016/j.arbres.2011.12.009. Epub 2012 Feb 15. Arch Bronconeumol. 2012. PMID: 22341911 English, Spanish.
57 results